Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagus Cancer, Stage I”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00711412
What this trial is testing

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Northwestern University 44
Early research (Phase 1)Study completedNCT00113581
What this trial is testing

Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)Study completedNCT00002984
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 520
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT03995017
What this trial is testing

Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma

Who this might be right for
Esophagus Cancer, AdenocarcinomaStomach Cancer, Adenocarcinoma
University of Kansas Medical Center 34
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00052910
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 546
Early research (Phase 1)Study completedNCT00281788
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Duke University 13
Early research (Phase 1)Study completedNCT02138929
What this trial is testing

LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma

Who this might be right for
Esophageal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00003748
What this trial is testing

Irinotecan in Treating Patients With Esophageal or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 40
Not applicableStudy completedNCT02027948
What this trial is testing

A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Localized Stage I-III Esophageal CancerGastroesophageal Junction Cancer
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)Ended earlyNCT02254044
What this trial is testing

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Who this might be right for
Carcinoma, Squamous Cell
Boehringer Ingelheim 7
Testing effectiveness (Phase 2)Study completedNCT00033657
What this trial is testing

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Eastern Cooperative Oncology Group 97
Large-scale testing (Phase 3)Ended earlyNCT02551458
What this trial is testing

Comparison of Systematic Surgery Versus Surveillance and Rescue Surgery in Operable Oesophageal Cancer With a Complete Clinical Response to Radiochemotherapy

Who this might be right for
Epidermoid Carcinoma orAdenocarcinoma of the Thoracic Oesophagus orAdenocarcinoma of the Oesogastric Junction (Siewert Type I or II)+1 more
Centre Hospitalier Universitaire Dijon 188
Testing effectiveness (Phase 2)Study completedNCT00021320
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fox Chase Cancer Center 21
Early research (Phase 1)Looking for participantsNCT05187182
What this trial is testing

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerStomach Cancer+2 more
Washington University School of Medicine 42
Early research (Phase 1)Study completedNCT01928524
What this trial is testing

Chemotherapy for Patients With Cancer of the Stomach

Who this might be right for
First-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus or
Per Pfeiffer 34
Load More Results